Stevenage, United Kingdom

Iain McFarlane McLay

USPTO Granted Patents = 3 


Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Iain McFarlane McLay: Innovator in Pharmaceutical Research

Introduction

Iain McFarlane McLay is a notable inventor based in Stevenage, GB, recognized for his contributions in the field of pharmaceutical inventions. With a total of three patents to his name, McLay focuses on developing innovative treatments for complex medical conditions.

Latest Patents

Among his latest inventions is a patented formulation of non-steroidal glucocorticoid inhibitors, aimed at treating inflammation, allergies, and autoimmune conditions. This invention provides compounds of a specific formula, detailing a comprehensive process for their preparation, and underscores their utility in manufacturing medicaments targeted towards therapeutic treatments. His other invention also revolves around similar compounds, emphasizing pharmaceutical compositions and their application in alleviating inflammation and allergic conditions.

Career Highlights

Iain McFarlane McLay is currently associated with Glaxo Group Limited, a leading player in the pharmaceutical industry. His work at this esteemed company underscores his commitment to advancing health solutions through innovative research and development.

Collaborations

Throughout his career, McLay has collaborated with esteemed coworkers, including Anthony William James Cooper and Keith Biggadike. These partnerships enhance his contributions to the field, fostering a collaborative environment that encourages creative solutions to pressing medical challenges.

Conclusion

Iain McFarlane McLay’s innovative spirit and dedication to pharmaceutical research position him as a key figure in medical invention. His patents reflect a profound understanding of how to address significant health issues, demonstrating his impact on both the industry and the lives of those affected by chronic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…